z-logo
Premium
Ultra‐fast liquid chromatography with tandem mass spectrometry determination of eight bioactive components of Kai‐Xin‐San in rat plasma and its application to a comparative pharmacokinetic study in normal and Alzheimer's disease rats
Author(s) -
Wang Xiaotong,
Zhang Yue,
Niu Huibin,
Geng Yajing,
Wang Bing,
Yang Xiaomei,
Yan Pengyu,
Li Qing,
Bi Kaishun
Publication year - 2017
Publication title -
journal of separation science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.72
H-Index - 102
eISSN - 1615-9314
pISSN - 1615-9306
DOI - 10.1002/jssc.201601343
Subject(s) - chromatography , chemistry , pharmacokinetics , tandem mass spectrometry , mass spectrometry , selected reaction monitoring , analyte , liquid chromatography–mass spectrometry , extraction (chemistry) , high performance liquid chromatography , pharmacology , medicine
A method of ultra‐fast liquid chromatography with tandem mass spectrometry was developed and validated for the simultaneous quantitation of eight bioactive components, including polygalaxanthone III, sibiricaxanthone B, tenuifolin, sibiricose A5, sibiricose A6, tenuifoliside A, ginsenoside Re and ginsenoside Rb1 in rat plasma after oral administration of Kai‐Xin‐San. The plasma samples were extracted by liquid–liquid extraction using digoxin as an internal standard. Chromatographic separation was performed on a Venusil MP C 18 column (100 mm × 2.1 mm, 3 μm) with methanol and 0.05% acetic acid in water as mobile phase. The tandem mass spectrometric detection was performed in the multiple reaction monitoring with turbo ion spray source in the negative ionization. Validation parameters were within acceptable ranges. The established method has been successfully applied to compare the pharmacokinetic profiles of the analytes between normal and Alzheimer's disease rats. The results indicated that there were significant differences in pharmacokinetic parameters of some components between two groups, which may be due to the mechanisms of Alzheimer's disease and pharmacological effects of the analytes. The pharmacokinetic research in the pathological state might provide more useful information to guide the clinical usage of herbal medicine.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here